---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-21-000099"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2021-12-08T23:59:59+00:00"
generated_at: "2026-06-28T02:48:21.486202+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies enters CFO employment agreement with $175K salary, stock option grant

## Summary
- CFO Robert E. Kristal employment agreement effective Nov 4, 2021, term through Nov 4, 2022.
- Annual salary of $175,000; eligible for discretionary bonus up to 30% of salary.
- Granted 10-year option to purchase 10,490 shares at $13.50 per share.
- Severance: if terminated without cause or resigns for good reason, receives lesser of remaining salary or 25% of current salary, paid over 3 months.
- One-year post-employment non-compete covering stem-cell therapy businesses in the US.

## SEC filing metadata
- accession: 0001021771-21-000099
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2021-12-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000099/0001021771-21-000099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000099/form8kdtd120321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-21-000099
- JSON: https://secwatch.observer/filing/0001021771-21-000099.json
- Plain text: https://secwatch.observer/filing/0001021771-21-000099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.